2020
DOI: 10.1038/s41598-020-77602-0
|View full text |Cite
|
Sign up to set email alerts
|

In silico studies evidenced the role of structurally diverse plant secondary metabolites in reducing SARS-CoV-2 pathogenesis

Abstract: Plants are endowed with a large pool of structurally diverse small molecules known as secondary metabolites. The present study aims to virtually screen these plant secondary metabolites (PSM) for their possible anti-SARS-CoV-2 properties targeting four proteins/ enzymes which govern viral pathogenesis. Results of molecular docking with 4,704 ligands against four target proteins, and data analysis revealed a unique pattern of structurally similar PSM interacting with the target proteins. Among the top-ranked PS… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

2
55
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 56 publications
(58 citation statements)
references
References 103 publications
2
55
0
Order By: Relevance
“…Researchers have suggested that any therapeutic of interest should be able to show a high affinity to binding and inhibiting the SARS-CoV-2 spike protein, main protease enzyme (Mpro) and RdRp which are associated with host attachment and viral replication, resulting in infection in the individual. This has been demonstrated through in silico studies which is a quick way to identifying potential drugs ( Table 1 ) (e.g Kar et al, 2020 ; Puttaswamy et al, 2020 ). The SARS-CoV-2 spike protein is known to attach itself to the human receptor ACE2 through the receptor binding domain (RBD), and this enables viral entry in host cells causing a breakdown in the system of the host (Tai et al, 2020).…”
Section: Natural Products As Possible Management/treatment Options Fomentioning
confidence: 99%
See 4 more Smart Citations
“…Researchers have suggested that any therapeutic of interest should be able to show a high affinity to binding and inhibiting the SARS-CoV-2 spike protein, main protease enzyme (Mpro) and RdRp which are associated with host attachment and viral replication, resulting in infection in the individual. This has been demonstrated through in silico studies which is a quick way to identifying potential drugs ( Table 1 ) (e.g Kar et al, 2020 ; Puttaswamy et al, 2020 ). The SARS-CoV-2 spike protein is known to attach itself to the human receptor ACE2 through the receptor binding domain (RBD), and this enables viral entry in host cells causing a breakdown in the system of the host (Tai et al, 2020).…”
Section: Natural Products As Possible Management/treatment Options Fomentioning
confidence: 99%
“…Hence extensive studies should be carried out on this phytocompound for the possible development of therapeutic against COVID-19. In another molecular docking study, Puttaswamy et al (2020) evaluated 4,704 ligands against four target proteins: Spike, RdRp, Mpro and the Human TMPRSS2 priming the SARS-CoV-2 spike protein. Authors observed a unique pattern of structurally similar interaction of some phytochemicals with the target proteins.…”
Section: Natural Products As Possible Management/treatment Options Fomentioning
confidence: 99%
See 3 more Smart Citations